VEGF and TMR: Myocardial revascularization: In the next millennium

American Journal of Critical Care

Volumn 8, Issue 5, 1999, Pages 349-353

  Futterman, Laurie G ^a   Lemberg, Louis ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

AGED; ANGINA PECTORIS; ARTICLE; CASE REPORT; FORECASTING; GENE TRANSFER; GENETICS; HEART MUSCLE REVASCULARIZATION; HUMAN; LASER SURGERY; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; COMBINED MODALITY THERAPY; ENDOTHELIAL GROWTH FACTORS; FORECASTING; GENE TRANSFER TECHNIQUES; HUMANS; LASER SURGERY; LYMPHOKINES; MALE; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033190650     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc1999.8.5.349     Document Type: Article

References (5)

1. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF as sole therapy for myocardial ischemia. Circulation. 1998;98:2800-2804.
2. Hariawala MD, Sellke FW. Angiogenesis and the heart: therapeutic implications. J R Soc Med. 1997;90:307-311.
3. Henry TD. Can we really grow new blood vessels? Lancet 1998,20: 1826-1827.
4. Isner JM. Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis [abstract]. Am J Cardiol. 1998;82(suppl 10A):63S.
5. Schaper W, Bushmann I. Collateral circulation and diabetes. Circulation. 1999;99:2224-2226.